01 358GILEAD SCIENCES INC
01 210039779*PED
02 210086011*PED
03 147964580
04 48088368
05 48273341
06 148334270
07 68575135
08 148580765
09 148618076
10 148633309
11 108735372
12 48822430
13 48841278
14 148889159
15 68921341
16 68940718
17 28957046
18 149085573
19 149284342
20 19296782
21 49393256
22 49511056
23 19549941
24 29757406
25 19868745
26 310039779
27 210086011
28 410456414
29 110912814
30 611116783
31 511116783*PED
32 211338007
33 111338007*PED
34 211707479
35 211707479*PED
36 137964580*PED
37 48088368*PED
38 48273341*PED
39 138334270*PED
40 58575135*PED
41 138580765*PED
42 138618076*PED
43 138633309*PED
44 98735372*PED
45 48822430*PED
46 48841278*PED
47 138889159*PED
48 58921341*PED
49 58940718*PED
50 139085573*PED
51 139284342*PED
52 49393256*PED
53 49511056*PED
54 19549941*PED
55 29757406*PED
01 133Y
02 225Blank
01 167Y
02 191Blank
01 542028-03-21
02 482028-09-21
03 432029-03-26
04 402029-09-26
05 202030-05-12
06 142030-09-13
07 202030-11-12
08 142030-12-11
09 132031-03-13
10 132031-06-11
11 82032-09-14
12 192032-11-16
13 42033-03-14
14 152033-05-16
15 152034-01-30
16 12034-07-17
17 132034-07-30
18 32037-06-01
19 12037-12-01
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8940718
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8575135
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2040
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8921341
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2032-11-16
US Patent Number : 8575135
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2032-11-16
Patent Expiration Date : 2028-03-21
US Patent Number : 8735372
Drug Substance Claim :
Drug Product Claim :
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2028-03-21
Patent Expiration Date : 2034-01-30
US Patent Number : 10086011
Drug Substance Claim :
Drug Product Claim :
Application Number : 208341
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2034-01-30
Patent Expiration Date : 2029-03-26
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204671
Patent Use Code : U-1470
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF H...
Patent Expiration Date : 2029-03-26
Patent Expiration Date : 2029-03-26
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
US Patent Number : 7964580
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 209195
Patent Use Code : U-2039
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-26
LOOKING FOR A SUPPLIER?
